Publications

Based on more than 50,000 assays with samples collected across over 150 sites, ClearNote Health has produced multiple peer-reviewed papers including detection data from several cancer types, including pancreatic and ovarian.

Journal / Event Publication Title Presentation Type Year
Blood Cancer Discovery The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia 2022
Cancer Research The 5-Hydroxymethylcytosine Landscape of Prostate Cancer 2022
American Pancreatic Association SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes 2023
Journal for ImmunoTherapy of Cancer Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non- small cell lung cancer 2023
medRxiv Pilot study demonstrating changes in DNA hydroxymethylation enable detection of multiple cancers in plasma cell-free DNA 2020
American Society of Clinical Oncology Multi-cohort validation of a multi-analyte liquid biopsy test for early-stage pancreatic cancer detection 2026
American Diabetes Association 83rd Scientific Sessions Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting 2023
American Association for Cancer Research Evaluation of the Avantect Pancreatic Cancer Test for Identifying High-Risk Pancreatic Cysts 2023
American Association of Cancer Research Epigenomic liquid biopsy for quantification of platinum and PARP inhibitor response in patients with germline BRCA-associated PDAC: A pilot study 2026
Clinical Gastroenterology and Hepatology Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA 2023